Mental health
fromPsychology Today
1 day agoMore on Low-Dose Sublingual Ketamine
Daily low-dose sublingual ketamine stimulates BDNF-driven neuroplasticity and sigma-1 receptors, providing sustained, safer, and inexpensive benefits for treatment-resistant depression than intermittent high doses.